sprite-preloader
Anzeige
Mehr »
Montag, 29.05.2017 Börsentäglich über 12.000 News von 573 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrPriority review for BMS' Opdivo in liver cancer
FrPfizer's Epogen/Procrit biosimilar wins US backing
FrUK researchers find evidence of 'nocebo' effect for statins
FrMerck buys experimental tau antibody from Teijin
DoEU regulators widen approval for Zebinix
DoUK biotech takes pole position in Europe
DoUlster Uni invests £2m in new health technology hub
DoGW Pharma poised to file Epidiolex in the US
MiUS approves Keytruda for MSI-H tumours
MiMSD accused of breaching UK competition law
MiFull green light for Biogen's MS drug Fampyra
MiNICE nod for psoriatic arthritis drugs Cimzia and Cosentyx
DiThe PharmaTimes Marketer of the Year competition is back, with a twist!
DiCommunications Team of the Year open for entry
DiNHS could lose more than 2,000 GPs through Brexit
DiUS approves first drug for giant cell arteritis
DiAstraZeneca asthma drug cuts oral steroid use
DiGreen light for Sanofi, Regeneron's Kevzara
22.05.Steering Group
22.05.How does it work
22.05.UK launch for Ferring's Rekovelle
22.05.Eleven therapies put forward for EU approval
22.05.AstraZeneca sells EU rights to Seloken, Logimax to Recordati
19.05.International Clinical Researcher of the Year - Winners announced
19.05.Mixed fortunes continue for Ionis rare disease drug inotersen